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SUMMARY
Objective: Although the general utility of voxel-based processing of structural mag-
netic resonance imaging (MRI) data for detecting occult lesions in focal epilepsy is
established, many differences exist among studies, and it is unclear which processing
method is preferable. The aim of this study was to compare the ability of commonly
used methods to detect epileptogenic lesions in magnetic resonance MRI-positive and
MRI-negative patients, and to estimate their diagnostic yield.
Methods: We identified 144 presurgical focal epilepsy patients, 15 of whom had a
histopathologically proven and MRI-visible focal cortical dysplasia; 129 patients were
MRI negative with a clinical hypothesis of seizure origin, 27 of whom had resections.
We applied four types of voxel-based morphometry (VBM), three based on T1 images
(gray matter volume, gray matter concentration, junction map [JM]) and one based
on normalized fluid-attenuated inversion recovery (nFSI). Specificity was derived from
analysis of 50 healthy controls.
Results: The four maps had different sensitivity and specificity profiles. All maps
showed detection rates for focal cortical dysplasia patients (MRI positive and negative)
of >30% at a strict threshold of p < 0.05 (family-wise error) and >60% with a liberal
threshold of p < 0.0001 (uncorrected), except for gray matter volume (14% and 27%
detection rate). All maps except nFSI showed poor specificity, with high rates of false-
positive findings in controls. In the MRI-negative patients, absolute detection rates
were lower. A concordant nFSI finding had a significant positive odds ratio of 7.33 for a
favorable postsurgical outcome in theMRI-negative group. Spatial colocalization of JM
and nFSI was rare, yet showed good specificity throughout the thresholds.
Significance: All VBM variants had specific diagnostic properties that need to be con-
sidered for an adequate interpretation of the results. Overall, structural postprocess-
ing can be a useful tool in presurgical diagnostics, but the low specificity of somemaps
has to be taken into consideration.
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In the evaluation for epilepsy surgery, magnetic reso-
nance imaging (MRI) has an important role in identify-
ing the structural basis of an epileptogenic network
that might be amenable to surgical resection. If the
clinical MRI is negative, chances of postoperative sei-
zure freedom are lower than in patients with a visually
apparent lesion.1,2 Even with optimal methodology, 10–
40%3–5 of presurgically evaluated patients have normal
MRI on visual inspection. Although other imaging
modalities, such as positron emission tomography
(PET), single photon emission computed tomography
(SPECT), magnetic, and electrical source imaging can
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be helpful to infer the localization of an epileptogenic
area, and successful surgery is possible in MRI-nega-
tive patients, an intracranial electroencephalography
(EEG) is usually necessary, which needs to be targeted
and carries expense and risks of morbidity. It is there-
fore desirable to increase the sensitivity of noninvasive
MRI. Focal cortical dysplasia (FCD) is the most com-
mon identifiable pathology underlying refractory epi-
lepsy that is not detected on MRI.6
Several postprocessing methods have been described,
mostly derived from voxel-based morphometry (VBM).7 In
contrast to studies in cognitive neuroscience, in which many
subjects are compared on a group level, the common
approach in clinical epilepsy is to compare a single patient
against a group of healthy controls. Although the general
utility of voxel-based postprocessing to improve lesion
detection in focal epilepsy is established,8 few direct
comparative studies exist.9 It is unclear which processing
method is preferable and how to optimally interpret a
VBM analysis, which may be crucial for surgical decision
making.
In the present study, we applied recent developments
in analytical processing methods such as high-dimen-
sional spatial normalization (DARTEL)10 and improved
segmentation/bias correction algorithms, allowing multi-
spectral segmentation in SPM8/SPM12,11 and compared
four commonly used VBM-processing routines (classical
T1-based VBM methods [gray matter concentration
(GMC), gray matter volume (GMV)], the junction map
[JM] based on the method of Huppertz et al.,12 and the
T2–fluid-attenuated inversion recovery [FLAIR]-based
VBM13) to compare their ability to detect epilepto-
genic lesions in 50 healthy controls and 144
patients, comprising a group of MRI-negative epilepsy
patients, some with postoperative results, and a group
of MRI-positive, histopathologically proven FCD
patients.
Methods
Subjects
We recruited the patients from a consecutive cohort of
patients with focal epilepsy who underwent presurgical
evaluation at the National Hospital for Neurology and Neu-
rosurgery from 2007 to 2013. Patients were included, if they
had (1) a visually evident and histopathologically proven
FCD or (2) a normal MRI on visual reporting. A total of 176
patients met these criteria. Patients without a hypothesis on
a single lobar level or with divergent results in the presurgi-
cal examinations were excluded (32 patients).
Thus, 144 patients (median age = 33 years, range =
17–61, 76 male) were available for the final analysis.
Twenty-seven of 129 MRI-negative patients had epilepsy
surgery, and histopathological data and clinical outcome
were available. Fifteen patients had a visually and
histopathologically evident FCD. All patients were scanned
on the Epilepsy Society 3 Tesla MRI (GE Signa HDx). All
scans were acquired with a specific epilepsy protocol and
reported by neuroradiologists who specialized in epilepsy.
The scanning paradigm consisted of high-resolution
volumetric T1-weighted fast spoiled gradient echo
(0.94 9 0.94 9 1.1 mm) and coronal fast spin-echo
T2-FLAIR (0.94 9 0.94 9 5 mm). We also included 50
healthy control subjects (median age = 43 years, range =
19–64) who underwent the same imaging protocol and
served as a normal database for all of the processing streams
to ensure equal testing conditions. All scans were acquired
in the oblique coronal plane perpendicular to the long axis
of the hippocampus.
Video-EEG telemetry was carried out at the National
Hospital for Neurology and Neurosurgery and reported by
experienced neurophysiologists and neurologists. The
results of the voxel-based image processing were not avail-
able at that time and therefore did not influence the evalua-
tion. This study was approved by the research ethics
committee of the National Hospital for Neurology and Neu-
rosurgery and the Institute of Neurology as a retrospective
evaluation of clinically acquired data.
MRI processing
All original DICOM images were converted to NIFTI for-
mat using MRIConvert (http://lcni.uoregon.edu/~jolinda/
MRIConvert/) and processed offline on a Linux-based
workstation. The processing was done using SPM12 (http://
www.fil.ion.ucl.ac.uk/spm/) running in MATLAB R2014b
(MathWorks, Natick, MA, U.S.A.).
T1-based stream (VBM and JMs)
This processing stream was based solely on T1-weighted
images; T2-FLAIR images were not used. Segmentation
was done separately as a single-channel approach, using the
“new segment” algorithm of SPM12 with default settings.
We used DARTEL normalization to spatially normalize the
Key Points
• All VBM variants show specific diagnostic properties
that need to be considered for an adequate interpreta-
tion
• VBM based on T2-FLAIR had the best specificity;
junction map had the best sensitivity
• VBM based on gray matter volume had the lowest sen-
sitivity, with a low specificity, and appears the least
favorable
• Detection of a lesion with normalized FLAIR was
associated with a better prognosis for good surgical
outcome
• Spatial colocalization of different maps, especially
junction map and normalized FLAIR, can improve the
confidence in a finding
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gray matter segmentations to Montreal Neurological Insti-
tute (MNI) space. We also generated a junction image,12
that is, a binary image of the voxels with intensities between
the gray matter mean + 0.5 standard deviation (SD) and the
white matter mean  0.5 SD. We applied the same brain
masking as in the normalized FLAIR (nFSI) stream. Finally,
the brain masked JMs were smoothed with an 8-mm full
width at half maximum (FWHM) Gaussian kernel.
The gray matter segmentations were separately pro-
cessed in a conventional VBM approach. The gray matter
maps were normalized both with (GMV) and without
modulation (GMC). Modulation (i.e., multiplication of the
resulting gray matter maps with the Jacobian determi-
nants) was used to account for the effects of spatial nor-
malization and was intended to preserve the absolute
GMV. Finally, the normalized gray matter maps were also
smoothed with an 8-mm FWHM Gaussian kernel. For the
volume analysis, the total intracranial volume was esti-
mated by summing the gray matter, white matter, and
cerebrospinal fluid (CSF) probability maps. This value
was used as a covariate of no interest in the general linear
model (GLM) analysis to account for global size differ-
ences. Because it is difficult to match age in a single sub-
ject versus group comparison, we also included age as a
covariate of no interest into all GLMs.
T2-FLAIR–based stream (nFSI)
T2-FLAIR images were coregistered to the high-resolu-
tion T1-weighted images using a normalized mutual infor-
mation cost function in SPM. Both images (T1 and
coregistered T2-FLAIR) were simultaneously segmented
into tissue classes using the multispectral unified segmenta-
tion algorithm (new segment) of SPM12 with a default set-
ting (bias regularization = 0.001, bias cutoff = 60 mm).11
This procedure also yields a bias-corrected T2-FLAIR
image. This step is a modification of our previous normal-
ized T2-FLAIR signal intensity processing stream
13 that
relied on a separate bias-correction of T2-FLAIR images.
This new approach should improve gray/white matter con-
trast of T1-weighted images. Visual inspection showed an
excellent bias correction and improved segmentation of
nonbrain classes (dura, venous sinuses) of this multispectral
segmentation compared to a single-channel approach. The
spatial normalization of T2-FLAIR images to MNI space
was accomplished with high-dimensional diffeomorphic
normalization (DARTEL normalization).10 After spatial
normalization, the T2-FLAIR images were intensity-nor-
malized with the modification that the whole brain white
matter (SPM white matter segmentation > 0.5) was used as
a reference region.14 Figure 1 summarizes the different
postprocessing workflows.
Figure 1.
Processing streams for revised T2 fluid-attenuated inversion recovery (FLAIR; left) and T1-FLAIR (right). A schematic processing scheme
of T2-FLAIR (normalized; left) and T1 images (right) is shown. Images were segmented, spatially and intensity-normalized, brain masked,
smoothed, and finally analyzed using a general linear model (GLM). The right part of the figure shows the processing of T1-weighted
images. These were segmented (modulated and unmodulated gray matter segmentation), normalized, and smoothed. Junction maps (JMs)
were generated from the bias-corrected, normalized T1-weighted image, brain masked, and also smoothed. GMC, gray matter concentra-
tion; GMV, gray matter volume.
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The three distinct T1 maps and the normalized T2-FLAIR
preprocessed images of each subject were then used in a
GLM comparing each map against the group of controls at
two different significance thresholds:
An uncorrected threshold of p < 0.0001.
A threshold of p < 0.05, corrected for multiple compar-
isons with the family-wise error rate (FWE).
We used a two-tailed t contrast to assess increases and
decreases in GMC and volume as signs of focal cortical
hypertrophy/atrophy. For JM and normalized T2-FLAIR,
we used only a one-tailed t contrast, as only increase of blur-
ring of the gray/white matter junction and hyperintensity on
T2-weighted images are described features of FCDs.
15
Figure 2 shows an example visualization of the postpro-
cessing results as well as the influence of different threshold
levels.
Analysis
In a leave-one-out strategy (i.e., removing one subject
from the control group and testing against the remainder),
we visually analyzed each of the 50 control subjects for
findings in the four VBM maps (GMC, GMV, JM, nFSI).
These were considered to be false positive, and can thus be
used to estimate the specificity of the different maps. Speci-
ficity was defined as follows:
specificity ¼
healthy controls without
VBM findings (true negative)
total number of healthy controls
Afterward, we visually analyzed the histopathologically
confirmed FCD patients (MRI positive and negative) for
suprathreshold clusters in the four different maps in the
resected area (true-positive findings) and outside the
resected area. The area resected was determined on postop-
erative scans, after nonlinear coregistration to the preopera-
tive scans to account for postsurgical brain deformation. For
three of the 27 operated patients, no postoperative scans
were available, so that we had to assume the whole operated
lobe as the resection zone. We subdivided the findings into
“concordant with the resection area” (=concordant find-
ings), equivalent to sensitivity, and “discordant with the
resection area” (=discordant findings). Sensitivity was
derived from all patients with a histopathologically proven
FCD (MRI positive and negative). We also calculated the
95% confidence interval (CI) for sensitivity and speci-
ficity.16 Statistical advice was provided by the Institute for
Clinical Epidemiology and Applied Biometry, T€ubingen.
For patients without resection, the seizure origin was esti-
mated on a lobar level based on clinical video-EEG (ictal
and interictal EEG, seizure semiology), neuropsychology,
and auxiliary examinations (PET, magnetoencephalography
[MEG]) as derived from the clinical case conferences. We
accepted a bilateral hypothesis, if it could be specified on a
lobar level, that is, bitemporal, bifrontal, or bioccipital. One
hundred twenty-six of the 129 patients underwent PET
(97.7%), 27 MEG (20.9%), and 15 ictal SPECT (11.6%) to
further support the hypothesis of seizure origin. We desig-
nated VBM findings in the lobe of hypothesized seizure ori-
gin as “concordant with the consensus of other data” and
findings outside of the lobe of suspicion as “discordant with
the consensus of other data.” Any findings that clearly did
not underlie focal epilepsy, for example, intraventricular
signal abnormalities due to CSF flow or deep white matter
lesions due to small vessel disease, were not considered rel-
evant in any group. Due to the deep location of the insula, it
is difficult for scalp EEG to establish the hypothesis of an
insular focus and to differentiate insular seizures from fron-
tal, temporal, or parietal lobe seizures.17 As such, we, a pri-
ori, did not consider the insula as a separate lobe but tried to
ascribe the findings to the connected lobes in a clinical con-
text. This scenario became relevant for just a single patient,
in whom it was also clinically plausible to declare the insu-
lar VBM finding as concordant with a hypothesis in the
rolandic area.
We additionally analyzed the spatial overlap of each map
with one or more of the other three maps in and outside the
suspected lobe; overlapping was defined as at least direct
contact of two voxels of different maps.
A study tree of the different cohorts is shown in Fig. 3.
Results
Healthy controls and specificity
In the healthy controls at a threshold of p < 0.05 (FWE),
the false-positive rates were 10.0–68.0% (Table S1). nFSI
had the lowest rate of false-positive findings with 10.0%,
followed by GMV with 34.0%. GMC and JM had higher
rates of 58.0% and 68.0%, respectively.
The more liberal threshold of p < 0.0001 (uncorrected)
led to a considerably higher number of findings, with up to
100% in GMC and JM. The hierarchy of the four maps
remained the same. Colocalization of false-positive findings
in GMC/GMV was most frequent, with each being present
in 46.0% of the cases at the low threshold. Other combina-
tions were much less frequent. For p < 0.05 (FWE), only
three overlaps were found in total (one each for GMC/JM,
GMV/JM, GMC/JM/nFSI). For details, please refer to
Table S2.
Specificity (shown in Fig. 4A1 + 2; see Table S1 for
details) for GMC and JM was poor, with 0.0% for
p < 0.0001 (uncorrected). nFSI showed the best specificity,
with 68.0%. A threshold of p < 0.05 (FWE) led to fewer
findings and, consequently, to higher specificity in all maps
with the same hierarchy, JM remaining the lowest (32.0%)
and nFSI (90.0%) the highest.
Histopathologically proven FCD group and sensitivity
In the MRI-positive group of 15 patients with FCD at a
threshold of p < 0.05 (FWE), GMC, JM, and nFSI had
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concordant findings in 40.0%, 46.7%, and 60.0%. GMV, in
contrast, had the poorest results, with only 13.3% concor-
dant findings. Discordant findings were absent in nFSI,
whereas each of the other maps showed more discordant
than concordant findings. A threshold of p < 0.0001 (uncor-
rected) yielded a higher rate of concordant findings for all
four maps. Up to 86.7% of the patients had a concordant
finding in JM, and discordant findings increased to up to
100% in JM. For nFSI, the positive ratio of concordant find-
ings remained, but 46.7% discordant findings emerged as
well. Please find visualization in Fig. 4A1 + 2 and details in
Table S1.
In the seven patients with histopathologically proven
FCD but negative MRI, the number of concordant findings
was considerably lower for all maps, with a maximum
detection rate of 42.9% for JM and nFSI, increasing to
Figure 2.
Example of voxel-based morphometry (VBM) findings. (A1) The upper native T2–fluid-attenuated inversion recovery (FLAIR)-weighted
image shows a focal cortical dysplasia (FCD) in the frontal operculum with characteristic hyperintensity and blurring of the gray–white
matter zone. (A2) The influence of different thresholds on size and amount of VBM findings. Note that the extent of the normalized
FLAIR (nFSI) cluster at a threshold of p < 0.0001 (uncorrected [uncorr.]; orange, 471 voxels) is nearly twice as large as the cluster at a
threshold of p < 0.05 (family-wise error rate [FWE]; dark red, 905 voxels) and covers the visible dimension of the lesion more effectively.
(B1, B2) A patient of the magnetic resonance imaging–negative group, who was operated on and histopathology showed FCD type IIa.
(B1) Postoperative resection. (B2) In projection upon this area (yellow), VBM of the preoperative scan shows concordant finding in gray
matter concentration (GMC) and junction map (JM). (C1) A patient with a hypothesized left temporal epileptogenic focus who did not
undergo surgery. A left temporal finding with overlap of three maps (JM, GMC, nFSI), matching the hypothesis, is visualized. C1 also indi-
cates the high rate of findings discordant with other data (for JM in particular). Note the patchy nonlocalizing distribution of these findings.
GMV = gray matter volume.
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57.1% at p < 0.0001 (uncorrected). NFSI was the only map
with more concordant than discordant findings at both
thresholds (details are shown in Table S4).
Taking all histopathologically proven FCD patients
together, there was sensitivity at p < 0.05 (FWE) of 31.8%
for GMC, 45.5% for JM, and 54.5% for nFSI. GMV yielded
the poorest results, with 13.6%. For p < 0.0001 (uncor-
rected), sensitivity increased up to 63.3% in GMC, 77.3% in
JM, 72.7% in nFSI, and 27.3% in GMV. Figure 4 illustrates
the range of sensitivities.
Concordant colocalizations in multiple maps were rare.
The combination of JM/nFSI showed the highest sensitivity
of 20.0% and no discordant findings in the MRI-positive
group. In the MRI-negative group, numbers were smaller,
with only one concordant finding per map (equivalent to
14.3% concordant findings). Taken together, the combina-
tion of JM/nFSI showed the best specificity, with 18.2% and
no discordant findings. Further combinations performed
more poorly, especially GMC/GMV, which showed nearly
exclusively discordant findings. Details are shown in
Table S2.
MRI-negative patient group
The detection rates were considerably lower than in the
FCD group. The highest values for p < 0.05 (FWE) were
found in GMC with 31.8%, followed by JM with 27.9%.
nFSI and GMV were 10.1% and 8.5%, respectively. All
maps except for nFSI had about three times more discordant
than concordant findings.
The more liberal threshold of p < 0.0001 (uncor-
rected) gave more concordant findings for all four maps,
GMC (66.7%), JM (65.1%), nFSI (33.3%), and GMV
(32.6%), at the cost of more discordant findings of
99.2% in GMC, 98.4% in JM, 74.4% in GMV, and
47.3% in nFSI. Concordant overlap of maps with more
concordant than discordant findings was seen in JM/
nFSI, with 6.2% concordant findings in patients. In con-
trast, discordant findings of GMC/GMV were found in
44.2% of the patients (Table S2).
Separate analysis for temporal and extratemporal
hypotheses showed no significant difference at a level of
p < 0.05, using two-tailed Fisher exact test. There was a
trend toward more concordant findings between imaging
Figure 3.
Study tree. This figure gives an overview of the patients included in this study, comprising 144 focal epilepsy patients, including 15 epilepsy
patients with a preoperatively diagnosed and postoperatively histopathologically proven focal cortical dysplasia (FCD) and 129 epilepsy
patients who had normal magnetic resonance imaging (MRI). Twenty-seven of these patients had epilepsy surgery, of whom seven had a
histopathologically proven FCD, eight had hippocampal sclerosis (HS), seven had gliosis, four were nonspecific and one had amygdala
hamartoma (A.H.). The postoperative outcome is indicated based on the International League Against Epilepsy (ILAE) classification 1–6;
a good outcome was defined as ILAE classification = 1–2, poor outcome as ILAE classification = 3–6. In total, 14 had a good (ILAE classifi-
cation = 1–2), 13 a poor (ILAE classification = 3–6) postoperative outcome at 1–7 years (average follow-up = 3.3 years). The duration of
postoperative follow-up for each patient is indicated following the ILAE classification.
Epilepsia ILAE
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and clinical-EEG data in extratemporal hypotheses for all
maps except for nFSI at p < 0.0001 (uncorrected; see
Table S3 for further details).
Operated subgroup inMRI-negative patients
The analysis of the operated MRI-negative patients
and the further subdivision based on histopathology is
shown in Figs. 5 and 6 (detailed numbers in Tables S4
and S5).
Compared to the whole MRI-negative group of 129
patients, there was a tendency of fewer concordant findings
in those patients in whom the histopathological results were
nonspecific or gliosis (11 of 27). The FCD subgroup had a
higher rate of positive findings (see above).
There was more likely to be a good outcome (Interna-
tional League Against Epilepsy outcome classification
groups 1–218), if there was a concordant finding in nFSI at
p < 0.0001 (uncorrected; odds ratio = 7.33, 95% CI = 1.16–
46.24; Table S6). The odds ratios for other contrasts and
thresholds were not significant.
Some colocalizations were also associated with a
better outcome, but numbers were low and therefore of
limited clinical use (Table S7). JM/nFSI combinations
yielded a positive odds ratio of 3.0 at both thresholds.
Figure 4.
Graphical overview of voxel-based morphometry (VBM) findings in the different cohorts. This figure summarizes the VBM findings in the
different cohorts (healthy controls, magnetic resonance (MRI)-positive and MRI-negative focal cortical dysplasia [FCD] patients, MRI-
negative patients) for each analyzed map (gray matter concentration [GMC], gray matter volume [GMV], junction map [JM], nFSI = nor-
malized T2–fluid-attenuated inversion recovery [nFSI]). (A1, B1) Findings for a threshold of p < 0.0001 (uncorrected [uncorr.]). (A2,
B2) Findings for a stricter threshold of p < 0.05 (family-wise error rate [FWE]). Sensitivity (A1,A2) was derived from true-positive find-
ings in histopathologically proven FCD patients (n = 22, 15 MRI-positive, 7 MRI-negative), specificity (A1, A2) from findings in healthy
controls (n = 50). For MRI-negative patients (B1, B2), findings were categorized into those that were concordant with the hypothesis
and those that were not (discordant). (B1,B2) VBM findings in the whole MRI-negative cohort (n = 129).
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Discussion
We compared four variants of VBM, three based on T1
(GMV, GMC, JM), and one on normalized T2-FLAIR, for
their ability to detect epileptogenic lesions in MRI-positive,
histopathologically proven FCD patients and MRI-negative
epilepsy patients at two different thresholds (p < 0.05
[FWE] and p < 0.0001 [uncorrected]).
Key findings
The maps had different characteristics concerning speci-
ficity in healthy controls and sensitivity in patients with
histopathologically proven FCD. All maps showed sensitiv-
ity of >30% at a strict threshold of p < 0.05 (FWE) and
>60% with a liberal threshold of p < 0.0001 (uncorrected),
except for GMV (13.6% and 27.3% detection rate). JM had
the highest sensitivity (45–77%), followed by GMC.
Normalized FLAIR had a reasonable balance of sensi-
tivity and specificity for detecting FCD at a threshold of
p < 0.05 (FWE; sensitivity of 55%, specificity of 90%).
All other maps showed poor specificity, with high rates
of false-positive findings in controls. GMV had the low-
est sensitivity, with a low specificity, and so appears to
be the least favorable. This poor performance is likely
methodologically inherent due to the modulation, which
could attenuate focal gray matter differences or introduce
global biological variance, for example, due to dis-
tributed atrophy.
In the more heterogeneous group of MRI-negative
patients, this profile was similar, but with much fewer
Figure 5.
Graphical overview of voxel-based morphometry (VBM) findings in the subgroup of operated magnetic resonance (MRI)-negative
patients. This figure summarizes the VBM findings in the MRI-negative subgroups with good (International League Against Epilepsy [ILAE]
classification = 1–2) and poor (ILAE classification = 3–5) postsurgical outcome for each map (gray matter concentration [GMC], gray
matter volume [GMV], junction map [JM], nFSI = normalized T2–fluid-attenuated inversion recovery [nFSI]) at two different thresholds:
(A1,B1) p < 0.0001 (uncorrected [uncorr.]); (A2,B2) p < 0.05 (family-wise error rate [FWE]).
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concordant findings. Normalized FLAIR only yielded 10–
33% concordant findings, and JM 28–65%.
In the subgroup of MRI-negative, histopathologically
proven FCD, VBM performed better than in the whole
MRI-negative group, yet more poorly than in the MRI-posi-
tive FCD group, with 43–57% concordant findings in JM
and nFSI, which is as expected given that the MRI-positive
group had visually evident abnormalities.
A good postoperative outcome was significantly posi-
tively associated with a concordant finding in JM and espe-
cially normalized FLAIR.
Spatial overlap of different maps can improve the confi-
dence in a finding, yet concordant combinations were rare.
A combination of JM and normalized FLAIR gave speci-
ficity of 100% and sensitivity of 18% for p < 0.05 (FWE).
Comparison to previous results
Our study compared commonly used VBM methods in
preoperative epilepsy diagnostics. Direct comparisons to
other studies are limited by technical differences, but we
achieved broadly similar results concerning sensitivity and
lesion detection. Wang et al.19 reported a detection rate of
65% for VBM postprocessing (MAP; includes a JM
approach) in a mixed cohort of 150 subtly lesional and non-
lesional epilepsy patients, which is comparable to our 65%
concordant findings in the MRI-negative group. They, how-
ever, reported a 27% false-positive rate in 52 healthy con-
trols, which is very different from our finding of 100% at
p < 0.0001 (uncorrected) and 68% at p < 0.05 (FWE). As
such, we cannot confirm their specificity estimate. This mis-
match may be explained by a different approach. They did
Figure 6.
Overview of voxel-based morphometry (VBM) findings in different histopathological subgroups. This figure summarizes the VBM findings
in subgroups of operated patients: patients with focal cortical dysplasia (FCD) and positive magnetic resonance imaging (MRI) (blue),
patients with FCD and negative MRI (red), and patients with a histopathological result other than FCD (green; gliosis, hippocampus scle-
rosis, nonspecific, amygdala hamartia). Each examined map is indexed separately (gray matter concentration [GMC], gray matter volume
[GMV], junction map [JM], nFSI = normalized T2–fluid-attenuated inversion recovery [nFSI]). (A1, B1) Findings for a threshold of
p < 0.0001 (uncorrected [uncorr.]). (A2, B2) Findings for a higher threshold of p < 0.05 (family-wise error rate [FWE]). Findings were
categorized into those that were situated inside the resection area (concordant;A1,A2) and those lying outside (discordant;B1,B2).
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not use a permutation method, but tested additional healthy
controls against a normative database of 150 controls from
different scanners, which may result in a bigger variance
and, hence, lower statistical significance. Wagner et al.20
showed in 91 mostly MRI-positive patients with histopatho-
logically proven FCD a detection rate of 90% with MAP,
which is comparable to our MRI-positive group with 87%
detection for p < 0.0001 (uncorrected). Yet at p < 0.05
(FWE), we found only 46% detections in our mixed group
of MRI-positive and MRI-negative FCD patients. Smaller
studies using MAP gave detection rates of 84–100%21–23 in
MRI-positive patients, but did not provide information on
specificity.
T1-based VBM studies of GMC and/or GMV showed a
similar correct detection of lesions at 63–91%,24–26 but no
information on false-positive findings were available. Sal-
menpera et al.9 came to a similar conclusion concerning
GMV, with a low detection rate of seven in 75 (9%).
In a previous cohort, we found similar sensitivity and
specificity for normalized FLAIR in MRI-positive FCD
patients (88% vs. 80%)13 for p < 0.05 (FWE).
Statistical thresholds
There is no established threshold in individual postpro-
cessing of MRI data. The applied threshold depends on the
clinical question and the characteristics of the particular
map. The specific profile of each map needs to be consid-
ered when drawing clinical interpretations. In particular,
when no threshold or a very liberal threshold is used, there
is a risk of overinterpretation. In terms of lesion detection,
we compared two cutoffs (p < 0.05 [FWE] and p < 0.0001
[uncorrected]). The threshold of p < 0.05 (FWE) is widely
used in various neuroimaging studies and hence can serve as
a reference point. However, this correction may be overly
strict in the case of subtle lesions. Some studies used more
liberal thresholds of p < 0.001 (Pail et al.24) or even
p < 0.05 (Riney et al.,27 Braga et al.28) without correction.
Because in our analysis, GMC and JM already reached a
specificity of 0% for p < 0.0001 (uncorrected), we argue
that with an even more liberal threshold a positive finding
may be very difficult to interpret and hence used p < 0.0001
uncorrected as a liberal threshold.
Also, other technical factors of the analysis can be varied,
namely the smoothing kernel/FWHM, the spatial normal-
ization, and voxel resolution. Here, we focused on a com-
mon approach using 8-mm FHWM Gaussian smoothing,
1.5-mm voxel size, and the state-of-the-art DARTEL nor-
malization. We wanted to assess the profile of fundamen-
tally different VBM approaches/maps and identify their
specific profiles. An important aspect is that we did not add
visual filtering of the findings, except for those that were
clearly spurious, to provide an objective comparison of the
different map profiles. Studies that employ visual filtering
raise the possibility of observer bias.
Sensitivity and specificity
It is debatable whether high sensitivity is preferable to
high specificity. Sensitivity is important to be sure that no
potential lesion has been overlooked, and to act as a screen-
ing test to complement visual inspection of MRI data. High
specificity helps to increase the confidence in the relevance
of a finding. Either way, the specific profile of each map has
to be considered. A positive finding in GMC or JM is of lit-
tle relevance, if it is not in keeping with the electroclinical
data. Conversely, the absence of a finding in nFSI will not
rule out the presence of a lesion. Although the specificity is
low, the presence of a concordant nFSI finding had a posi-
tive odds ratio for a good outcome. This is consistent with
the better outcome of lesional cases,26 including MRI-nega-
tive patients.19 These findings should therefore be consid-
ered when planning invasive EEG or epilepsy surgery. The
handling of discordant findings is, in contrast, more diffi-
cult, as some of them could indicate epileptogenic lesions
outside the suspected area, for example, in multifocal cases,
but also be false positives. Currently, this question cannot
be reliably addressed; further studies such as that of Wang
et al.,29 with longer follow-up, for example, after reopera-
tions in previously unsuccessful cases, are needed.
Limitations
Our data analysis was retrospective, and the more robust
comparison of VBM findings with surgical outcome and
histology of the resection was only possible in 29% of our
cohort of 144 patients. The classification for the other MRI-
negative patients depended on the hypothesis that was
derived from a best-available standard in a large tertiary epi-
lepsy center, yet still prone to error and not definitive in
many cases. Misclassification of findings are, therefore,
likely to occur. Moreover, it is possible that even
histopathologically proven FCD patients had multifocal
structural abnormalities outside of the resection area, which
are not referred to as concordant. Although our patients
were recruited from a consecutive cohort, a selection bias
was introduced by not including patients with divergent,
multifocal, or unclear presurgical evaluations. Therefore,
our MRI-negative results cannot be directly transferred to
all MRI-negative patients, particularly those without any
clinical hypothesis.
Given the retrospective nature of our study (with acquisi-
tions from 2007), we had to rely on an anisotropic
two-dimensional (2D) FLAIR dataset that was part of the
standard clinical protocol at that time. It is possible that iso-
tropic high-resolution/3D T2-FLAIR, for example, as used
in Adler et al.,30 would further improve the results in the
FLAIR-based stream.
Compared to several other studies on lesion detection in
epilepsy,9,24,25,27 the size of the control group (n = 50) was
relatively large. However, we cannot exclude that even lar-
ger control group sizes could further improve the results.
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Significance
In summary, our study demonstrates the strengths and lim-
itations of different VBM approaches in epilepsy imaging.
Ongoing work to increase the pickup of subtle structural
cerebral abnormalities include postprocessing methods such
as surface-based morphometry, quantitative contrasts (dif-
fusion and perfusion imaging, T2-/T1-relaxometry, magneti-
zation transfer imaging), and use of higher magnetic field
strengths. Furthermore, it would be valuable to assess a lar-
ger cohort of epilepsy patients from different centers in col-
laborative efforts. In all VBM approaches, a keen awareness
of the importance of specificity as well as sensitivity, and of
concordance with clinical and EEG data, is paramount.
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group of operated MRI-negative patients.
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